Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lawrence Piro"'
Autor:
John R. Power, Joachim Alexandre, Arrush Choudhary, Benay Ozbay, Salim S. Hayek, Aarti Asnani, Yuichi Tamura, Mandar Aras, Jennifer Cautela, Franck Thuny, Lauren Gilstrap, Dimitri Arangalage, Steven Ewer, Shi Huang, Anita Deswal, Nicolas L. Palaskas, Daniel Finke, Lorenz H. Lehmann, Stephane Ederhy, Javid Moslehi, Joe-Elie Salem, Charlotte Fenioux, Baptiste Abbar, Yves Allenbach, Shanthini M. Crusz, Arjun K. Ghosh, Tyler Moran, Tyler Mehegan, Lawrence Piro, Wei-Ting Chang, Johnny Chahine, Danette Flint, Ben Stringer, Valérie Gounant, Martin Nicol, Barouyr Baroudjian, Marie-Claire Zimmer, Elvire Mervoyer, Darryl Leong, Ryota Morimoto, Nicolas Piriou, Cecilia Monge, Amy Copeland, Kambiz Ghafourian, Avirup Guha, Sergey Brodsky, Osnat Itzhaki Ben Zadok, Manhal Habib, Grace Dy, Ellen Warner, Michal Laufer-Perl, Lily Koo Lin, Ana Narezkina, Alan Baik, Carrie Lenneman, Pankit Vachhani, Tariq U. Azam, Daniel Perry, Pennelope Blakely, Kazuko Tajiri, Matthew Martini, Joseph Nowatzke, Olusola Ayodeji Orimoloye, Andrew Hughes, Lauren A. Baldassarre, Milan Patel
Publikováno v:
Archives of Cardiovascular Diseases. 115:315-330
Immune-checkpoint inhibitor-associated myocarditis (ICI-myocarditis) often presents with arrhythmias, but the prognostic value of early electrocardiogram findings is unclear. Although ICI-myocarditis and acute cellular rejection (ACR) following cardi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58e4ec61fb20dd27dd3593c655c8cc5c
https://doi.org/10.1016/j.acvd.2022.03.003
https://doi.org/10.1016/j.acvd.2022.03.003
Autor:
Artak Labadzhyan, Kristopher Wentzel, Omid Hamid, Kamlynn Chow, Sungjin Kim, Lawrence Piro, Shlomo Melmed
Publikováno v:
J Clin Endocrinol Metab
Context Incidence and awareness of endocrine-related adverse events (ERAE) associated with use of immune checkpoint inhibitors (ICI) has grown with increased ICI use, yet mechanisms for ERAE prediction, surveillance, and development are not well esta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e98d0cae8e98e3df78860e6593a6ac3
https://europepmc.org/articles/PMC9202695/
https://europepmc.org/articles/PMC9202695/
Publikováno v:
The New England journal of medicine. 330(10)
Hairy-cell Leukemia, or leukemic reticuloendotheliosis, is an uncommon chronic lymphoproliferative disorder first described by Bouroncle et al. in 19581. Its defining features are mononuclear cells with prominent cytoplasmic projections (Figure 1) th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::357df1199cdf3180c97d78504f9e17d4
https://pubmed.ncbi.nlm.nih.gov/7906385
https://pubmed.ncbi.nlm.nih.gov/7906385
Autor:
Lisa Meng, Gail L. Brown, Leonel Ochoa, Stephanie F. Williams, Naomi Galili, Peter D. Emanuel, Natalie S. Callander, Stefan Faderl, James G. Keck, Lawrence Piro, Azra Raza, Peter T. Curtin, Richard A. Larson, Marsha Jones, Zeev Estrov, Howard A. Burris
Publikováno v:
Journal of Hematology & Oncology, Vol 2, Iss 1, p 20 (2009)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Background Ezatiostat hydrochloride liposomes for injection, a glutathione S-transferase P1-1 inhibitor, was evaluated in myelodysplastic syndrome (MDS). The objectives were to determine the safety, pharmacokinetics, and hematologic improvement (HI)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f4a31b8bfadcc3680bad14d01950391